The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Measles and Rubella (MR) Vaccine Market Research Report 2025
Synopsis
The global Measles and Rubella (MR) Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Measles and Rubella (MR) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles and Rubella (MR) Vaccine.
Report Scope
The Measles and Rubella (MR) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Measles and Rubella (MR) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles and Rubella (MR) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PT Bio Farma
Bio-Manguinhos
BE Vaccines
Crucell Switzerland AG
Segment by Type
MR Vaccine
MRBEV Vaccine
Segment by Application
Private Distribution Channel
Public Distribution Channel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measles and Rubella (MR) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measles and Rubella (MR) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Measles and Rubella (MR) Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Measles and Rubella (MR) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles and Rubella (MR) Vaccine.
Report Scope
The Measles and Rubella (MR) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Measles and Rubella (MR) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Measles and Rubella (MR) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PT Bio Farma
Bio-Manguinhos
BE Vaccines
Crucell Switzerland AG
Segment by Type
MR Vaccine
MRBEV Vaccine
Segment by Application
Private Distribution Channel
Public Distribution Channel
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Measles and Rubella (MR) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Measles and Rubella (MR) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Measles and Rubella (MR) Vaccine Market Overview
1.1 Product Overview and Scope of Measles and Rubella (MR) Vaccine
1.2 Measles and Rubella (MR) Vaccine Segment by Type
1.2.1 Global Measles and Rubella (MR) Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 MR Vaccine
1.2.3 MRBEV Vaccine
1.3 Measles and Rubella (MR) Vaccine Segment by Application
1.3.1 Global Measles and Rubella (MR) Vaccine Market Value by Application: (2024-2030)
1.3.2 Private Distribution Channel
1.3.3 Public Distribution Channel
1.4 Global Measles and Rubella (MR) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Measles and Rubella (MR) Vaccine Revenue 2019-2030
1.4.2 Global Measles and Rubella (MR) Vaccine Sales 2019-2030
1.4.3 Global Measles and Rubella (MR) Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Measles and Rubella (MR) Vaccine Market Competition by Manufacturers
2.1 Global Measles and Rubella (MR) Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Measles and Rubella (MR) Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Measles and Rubella (MR) Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Measles and Rubella (MR) Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Product Type & Application
2.7 Measles and Rubella (MR) Vaccine Market Competitive Situation and Trends
2.7.1 Measles and Rubella (MR) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Measles and Rubella (MR) Vaccine Players Market Share by Revenue
2.7.3 Global Measles and Rubella (MR) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Measles and Rubella (MR) Vaccine Retrospective Market Scenario by Region
3.1 Global Measles and Rubella (MR) Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Measles and Rubella (MR) Vaccine Global Measles and Rubella (MR) Vaccine Sales by Region: 2019-2030
3.2.1 Global Measles and Rubella (MR) Vaccine Sales by Region: 2019-2024
3.2.2 Global Measles and Rubella (MR) Vaccine Sales by Region: 2025-2030
3.3 Global Measles and Rubella (MR) Vaccine Global Measles and Rubella (MR) Vaccine Revenue by Region: 2019-2030
3.3.1 Global Measles and Rubella (MR) Vaccine Revenue by Region: 2019-2024
3.3.2 Global Measles and Rubella (MR) Vaccine Revenue by Region: 2025-2030
3.4 North America Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.4.1 North America Measles and Rubella (MR) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Measles and Rubella (MR) Vaccine Sales by Country (2019-2030)
3.4.3 North America Measles and Rubella (MR) Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.5.1 Europe Measles and Rubella (MR) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Measles and Rubella (MR) Vaccine Sales by Country (2019-2030)
3.5.3 Europe Measles and Rubella (MR) Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Measles and Rubella (MR) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Measles and Rubella (MR) Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Measles and Rubella (MR) Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.7.1 Latin America Measles and Rubella (MR) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Measles and Rubella (MR) Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Measles and Rubella (MR) Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Measles and Rubella (MR) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Measles and Rubella (MR) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Measles and Rubella (MR) Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Measles and Rubella (MR) Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Measles and Rubella (MR) Vaccine Sales by Type (2019-2030)
4.1.1 Global Measles and Rubella (MR) Vaccine Sales by Type (2019-2024)
4.1.2 Global Measles and Rubella (MR) Vaccine Sales by Type (2025-2030)
4.1.3 Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Measles and Rubella (MR) Vaccine Revenue by Type (2019-2030)
4.2.1 Global Measles and Rubella (MR) Vaccine Revenue by Type (2019-2024)
4.2.2 Global Measles and Rubella (MR) Vaccine Revenue by Type (2025-2030)
4.2.3 Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Measles and Rubella (MR) Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Measles and Rubella (MR) Vaccine Sales by Application (2019-2030)
5.1.1 Global Measles and Rubella (MR) Vaccine Sales by Application (2019-2024)
5.1.2 Global Measles and Rubella (MR) Vaccine Sales by Application (2025-2030)
5.1.3 Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Measles and Rubella (MR) Vaccine Revenue by Application (2019-2030)
5.2.1 Global Measles and Rubella (MR) Vaccine Revenue by Application (2019-2024)
5.2.2 Global Measles and Rubella (MR) Vaccine Revenue by Application (2025-2030)
5.2.3 Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Measles and Rubella (MR) Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 PT Bio Farma
6.1.1 PT Bio Farma Corporation Information
6.1.2 PT Bio Farma Description and Business Overview
6.1.3 PT Bio Farma Measles and Rubella (MR) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 PT Bio Farma Measles and Rubella (MR) Vaccine Product Portfolio
6.1.5 PT Bio Farma Recent Developments/Updates
6.2 Bio-Manguinhos
6.2.1 Bio-Manguinhos Corporation Information
6.2.2 Bio-Manguinhos Description and Business Overview
6.2.3 Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bio-Manguinhos Measles and Rubella (MR) Vaccine Product Portfolio
6.2.5 Bio-Manguinhos Recent Developments/Updates
6.3 BE Vaccines
6.3.1 BE Vaccines Corporation Information
6.3.2 BE Vaccines Description and Business Overview
6.3.3 BE Vaccines Measles and Rubella (MR) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BE Vaccines Measles and Rubella (MR) Vaccine Product Portfolio
6.3.5 BE Vaccines Recent Developments/Updates
6.4 Crucell Switzerland AG
6.4.1 Crucell Switzerland AG Corporation Information
6.4.2 Crucell Switzerland AG Description and Business Overview
6.4.3 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product Portfolio
6.4.5 Crucell Switzerland AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Measles and Rubella (MR) Vaccine Industry Chain Analysis
7.2 Measles and Rubella (MR) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Measles and Rubella (MR) Vaccine Production Mode & Process
7.4 Measles and Rubella (MR) Vaccine Sales and Marketing
7.4.1 Measles and Rubella (MR) Vaccine Sales Channels
7.4.2 Measles and Rubella (MR) Vaccine Distributors
7.5 Measles and Rubella (MR) Vaccine Customers
8 Measles and Rubella (MR) Vaccine Market Dynamics
8.1 Measles and Rubella (MR) Vaccine Industry Trends
8.2 Measles and Rubella (MR) Vaccine Market Drivers
8.3 Measles and Rubella (MR) Vaccine Market Challenges
8.4 Measles and Rubella (MR) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Measles and Rubella (MR) Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Measles and Rubella (MR) Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Measles and Rubella (MR) Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Measles and Rubella (MR) Vaccine Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Measles and Rubella (MR) Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Measles and Rubella (MR) Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Measles and Rubella (MR) Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Measles and Rubella (MR) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Measles and Rubella (MR) Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Measles and Rubella (MR) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles and Rubella (MR) Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Measles and Rubella (MR) Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Measles and Rubella (MR) Vaccine Sales by Region (2019-2024) & (Units)
Table 18. Global Measles and Rubella (MR) Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Measles and Rubella (MR) Vaccine Sales by Region (2025-2030) & (Units)
Table 20. Global Measles and Rubella (MR) Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Measles and Rubella (MR) Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Measles and Rubella (MR) Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Measles and Rubella (MR) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Measles and Rubella (MR) Vaccine Sales by Country (2019-2024) & (Units)
Table 27. North America Measles and Rubella (MR) Vaccine Sales by Country (2025-2030) & (Units)
Table 28. North America Measles and Rubella (MR) Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Measles and Rubella (MR) Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Measles and Rubella (MR) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Measles and Rubella (MR) Vaccine Sales by Country (2019-2024) & (Units)
Table 32. Europe Measles and Rubella (MR) Vaccine Sales by Country (2025-2030) & (Units)
Table 33. Europe Measles and Rubella (MR) Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Measles and Rubella (MR) Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Measles and Rubella (MR) Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Measles and Rubella (MR) Vaccine Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Measles and Rubella (MR) Vaccine Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Measles and Rubella (MR) Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Measles and Rubella (MR) Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Measles and Rubella (MR) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Measles and Rubella (MR) Vaccine Sales by Country (2019-2024) & (Units)
Table 42. Latin America Measles and Rubella (MR) Vaccine Sales by Country (2025-2030) & (Units)
Table 43. Latin America Measles and Rubella (MR) Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Measles and Rubella (MR) Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Country (2019-2024) & (Units)
Table 47. Middle East & Africa Measles and Rubella (MR) Vaccine Sales by Country (2025-2030) & (Units)
Table 48. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Measles and Rubella (MR) Vaccine Sales (Units) by Type (2019-2024)
Table 51. Global Measles and Rubella (MR) Vaccine Sales (Units) by Type (2025-2030)
Table 52. Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Measles and Rubella (MR) Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Measles and Rubella (MR) Vaccine Sales (Units) by Application (2019-2024)
Table 61. Global Measles and Rubella (MR) Vaccine Sales (Units) by Application (2025-2030)
Table 62. Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Measles and Rubella (MR) Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Measles and Rubella (MR) Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Measles and Rubella (MR) Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. PT Bio Farma Corporation Information
Table 71. PT Bio Farma Description and Business Overview
Table 72. PT Bio Farma Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. PT Bio Farma Measles and Rubella (MR) Vaccine Product
Table 74. PT Bio Farma Recent Developments/Updates
Table 75. Bio-Manguinhos Corporation Information
Table 76. Bio-Manguinhos Description and Business Overview
Table 77. Bio-Manguinhos Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bio-Manguinhos Measles and Rubella (MR) Vaccine Product
Table 79. Bio-Manguinhos Recent Developments/Updates
Table 80. BE Vaccines Corporation Information
Table 81. BE Vaccines Description and Business Overview
Table 82. BE Vaccines Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. BE Vaccines Measles and Rubella (MR) Vaccine Product
Table 84. BE Vaccines Recent Developments/Updates
Table 85. Crucell Switzerland AG Corporation Information
Table 86. Crucell Switzerland AG Description and Business Overview
Table 87. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Crucell Switzerland AG Measles and Rubella (MR) Vaccine Product
Table 89. Crucell Switzerland AG Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Measles and Rubella (MR) Vaccine Distributors List
Table 93. Measles and Rubella (MR) Vaccine Customers List
Table 94. Measles and Rubella (MR) Vaccine Market Trends
Table 95. Measles and Rubella (MR) Vaccine Market Drivers
Table 96. Measles and Rubella (MR) Vaccine Market Challenges
Table 97. Measles and Rubella (MR) Vaccine Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Measles and Rubella (MR) Vaccine
Figure 2. Global Measles and Rubella (MR) Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Measles and Rubella (MR) Vaccine Market Share by Type in 2023 & 2030
Figure 4. MR Vaccine Product Picture
Figure 5. MRBEV Vaccine Product Picture
Figure 6. Global Measles and Rubella (MR) Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Measles and Rubella (MR) Vaccine Market Share by Application in 2023 & 2030
Figure 8. Private Distribution Channel
Figure 9. Public Distribution Channel
Figure 10. Global Measles and Rubella (MR) Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Measles and Rubella (MR) Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Measles and Rubella (MR) Vaccine Sales (2019-2030) & (Units)
Figure 13. Global Measles and Rubella (MR) Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 14. Measles and Rubella (MR) Vaccine Report Years Considered
Figure 15. Measles and Rubella (MR) Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Measles and Rubella (MR) Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Measles and Rubella (MR) Vaccine Players: Market Share by Revenue in 2023
Figure 18. Measles and Rubella (MR) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Measles and Rubella (MR) Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Measles and Rubella (MR) Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Measles and Rubella (MR) Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Measles and Rubella (MR) Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Measles and Rubella (MR) Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Measles and Rubella (MR) Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Latin America Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Measles and Rubella (MR) Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Measles and Rubella (MR) Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Measles and Rubella (MR) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Measles and Rubella (MR) Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Measles and Rubella (MR) Vaccine by Type (2019-2030)
Figure 54. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Measles and Rubella (MR) Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Measles and Rubella (MR) Vaccine by Application (2019-2030)
Figure 57. Global Measles and Rubella (MR) Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 58. Measles and Rubella (MR) Vaccine Value Chain
Figure 59. Measles and Rubella (MR) Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
